Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Juma

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|August 25, 2017
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposureAbdirahman I Abdi, Susanne H Hodgson, Michelle K Muthui, et al.
Malaria Journal|January 30, 2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyBernhards R Ogutu, Kevin O Onyango, Nelly Koskei, et al.
Malaria Journal|May 1, 2015
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, KenyaSusanne H Hodgson, Elizabeth Juma, Amina Salim, et al.
Lancet (London, England)|October 18, 2008
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialSalim Abdulla, Issaka Sagara, Steffen Borrmann, et al.
Plos One|November 22, 2011
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastSteffen Borrmann, Philip Sasi, Leah Mwai, et al.
BMC Public Health|March 29, 2023
Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021Michael Rockson Adjei, Kwame Amponsa-Achiano, Rafiq Okine, et al.
Tropical Medicine & International Health : TM & IH|March 3, 2015
Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveysStephen Poyer, Tanya Shewchuk, Sarah Tougher, et al.
BMC Proceedings|January 25, 2026
Strengthening funding and integration for NTD elimination: insights from the 2025 Annual Meeting of National NTD Programme Managers in the WHO African RegionElizabeth Juma, Dorothy Achu, Abbie Barry, et al.
Malaria Journal|February 6, 2014
Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy interventionBarbara A Willey, Sarah Tougher, Yazoume Ye, et al.
BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|August 25, 2017
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposureAbdirahman I Abdi, Susanne H Hodgson, Michelle K Muthui, et al.
Malaria Journal|January 30, 2014
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre studyBernhards R Ogutu, Kevin O Onyango, Nelly Koskei, et al.
Malaria Journal|May 1, 2015
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, KenyaSusanne H Hodgson, Elizabeth Juma, Amina Salim, et al.
Lancet (London, England)|October 18, 2008
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialSalim Abdulla, Issaka Sagara, Steffen Borrmann, et al.
Plos One|November 22, 2011
Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastSteffen Borrmann, Philip Sasi, Leah Mwai, et al.
BMC Public Health|March 29, 2023
Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021Michael Rockson Adjei, Kwame Amponsa-Achiano, Rafiq Okine, et al.
Tropical Medicine & International Health : TM & IH|March 3, 2015
Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveysStephen Poyer, Tanya Shewchuk, Sarah Tougher, et al.
BMC Proceedings|January 25, 2026
Strengthening funding and integration for NTD elimination: insights from the 2025 Annual Meeting of National NTD Programme Managers in the WHO African RegionElizabeth Juma, Dorothy Achu, Abbie Barry, et al.
Malaria Journal|February 6, 2014
Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy interventionBarbara A Willey, Sarah Tougher, Yazoume Ye, et al.
BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.
Pageof 5